Charles River Laboratories (CRL) insider trading

By person

32 insiders · 3,089 transactions

9.4×

James C. Foster holds 9.4 times base salary in stock. $14.56M of shares against $1.55M in salary for 2025.

Salary from the company's own proxy. The shares are what James C. Foster last reported holding, valued at $350.00, the price Common Stock was last bought or sold at on the open market here, on 22 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

James C Foster

Director

$2.00M (2)

$183.13M (1546) scheduled

−$181.12M

243,410

0.5099%

$85.19M

−28.3%

David Ross Smith

Corporate Executive VP & CFO

—

$22.86M (427) scheduled

−$22.86M

25,819

0.0541%

$9.04M

+147.6%

William D Barbo

Corporate Executive VP & CCO

—

$19.46M (204) scheduled

−$19.46M

26,770

0.0561%

$9.37M

+61.3%

Joseph W LaPlume

EVP, Corp Strategy & Develop

$4.36K (1)

$16.48M (106) scheduled

−$16.48M

31,041

0.0650%

$10.86M

+139.0%

David P Johst

Corporate Executive VP

—

$14.28M (73) scheduled

−$14.28M

224,478

0.4702%

$78.57M

+39.6%

Birgit Girshick

Chief Executive Officer

$497.55K (2)

$14.31M (157) scheduled

−$13.81M

79,288

0.1661%

$27.75M

+243.0%

Davide Molho

President & COO

—

$10.83M (106) scheduled

−$10.83M

64,172

0.1344%

$22.46M

+10.1%

Shannon M Parisotto

CEVP, Disc & Safety Assessment

—

$8.12M (26) scheduled

−$8.12M

52,677

0.1103%

$18.44M

+27.9%

Victoria L Creamer

EVP & Chief People Officer

—

$6.47M (4) scheduled

−$6.47M

30,051

0.0629%

$10.52M

+421.7%

Michael Gunnar Knell

SVP, Finance and CAO

—

$4.84M (19) scheduled

−$4.84M

11,852

0.0248%

$4.15M

+1,380%

George Massaro

Director

—

$4.78M (157) scheduled

−$4.78M

5,575

0.0117%

$1.95M

−40.8%

George M Milne Jr

Director

—

$4.75M (5) scheduled

−$4.75M

29,079

0.0609%

$10.18M

+43.2%

Robert J Bertolini

Director

—

$4.35M (142) scheduled

−$4.35M

32,802

0.0687%

$11.48M

+62.8%

Deborah Turner Kochevar

Director

—

$3.09M (58) scheduled

−$3.09M

7,894

0.0165%

$2.76M

−23.2%

Richard F Wallman

Director

$2.59M (5)

$5.60M (9)

−$3.01M

12,386

0.0259%

$4.34M

+317.5%

Stephen D Chubb

Director

—

$2.08M (31) scheduled

−$2.08M

40,529

0.0849%

$14.19M

+120.5%

C Richard Reese

Director

—

$1.37M (3) scheduled

−$1.37M

65,541

0.1373%

$22.94M

+91.5%

Nancy C Andrews

Director

—

$163.44K (1) scheduled

−$163.44K

5,402

0.0113%

$1.89M

—

Glenn Coleman

EVP & Chief Financial Officer

$2.97K (1)

—

+$2.97K

27,762

0.0582%

$9.72M

—

Flavia Pease

Corporate Executive VP & CFO

—

17,297

0.0362%

$6.05M

—

Martin Mackay

Director

—

17,137

0.0359%

$6.00M

—

Mark Mintz

EVP, Chief Information Officer

—

9,546

0.0200%

$3.34M

+50.3%

George Llado Sr.

Director

—

6,702

0.0140%

$2.35M

—

Virginia M Wilson

Director

—

6,349

0.0133%

$2.22M

—

Reshema Kemps-Polanco

Director

—

4,563

0.0096%

$1.60M

—

Jean-Paul Mangeolle

Director

—

3,886

0.0081%

$1.36M

—

Craig B. Thompson

Director

—

3,851

0.0081%

$1.35M

—

Steven Barg

Director

—

3,287

0.0069%

$1.15M

—

John W Kuo

CEVP General Counsel & CCO

—

3,171

0.0066%

$1.11M

—

Paul W Graves

Director

—

2,384

0.0050%

$834.40K

—

Abraham Ceesay

Director

—

2,384

0.0050%

$834.40K

—

Mark J Enyedy

Director

—

2,384

0.0050%

$834.40K

—

Charles River Laboratories

What the insiders did Net selling

By person